95 related articles for article (PubMed ID: 19558618)
1. Neurofibromatosis type 1: should we screen for other genetic syndromes? A case report of co-existence with multiple endocrine neoplasia 2A.
Gkaliagkousi E; Erlic Z; Petidis K; Semertzidis P; Doumas M; Zamboulis C; Neumann HP; Douma S
Eur J Clin Invest; 2009 Sep; 39(9):828-32. PubMed ID: 19558618
[TBL] [Abstract][Full Text] [Related]
2. Genetic testing in multiple endocrine neoplasia and related syndromes.
Calender A
Forum (Genova); 1998; 8(2):146-59. PubMed ID: 9666051
[TBL] [Abstract][Full Text] [Related]
3. Multiple endocrine neoplasia (MEN)--an overview and case report--patient with sporadic bilateral pheochromocytoma, hyperparathyroidism and marfanoid habitus.
Fassbender WJ; Krohn-Grimberghe B; Görtz B; Litzlbauer D; Stracke H; Raue F; Kaiser HE
Anticancer Res; 2000; 20(6C):4877-87. PubMed ID: 11205236
[TBL] [Abstract][Full Text] [Related]
4. RET proto-oncogene mutations are restricted to codons 634 and 918 in mainland Chinese families with MEN2A and MEN2B.
Zhou Y; Zhao Y; Cui B; Gu L; Zhu S; Li J; Liu J; Yin M; Zhao T; Yin Z; Yu C; Chen C; Wang L; Xiao B; Hong J; Zhang Y; Tang Z; Wang S; Li X; Ning G
Clin Endocrinol (Oxf); 2007 Oct; 67(4):570-6. PubMed ID: 17573899
[TBL] [Abstract][Full Text] [Related]
5. Patient affected by neurofibromatosis type 1 and thyroid C-cell hyperplasia harboring pathogenic germ-line mutations in both NF1 and RET genes.
Ercolino T; Lai R; Giachè V; Melchionda S; Carella M; Delitala A; Mannelli M; Fanciulli G
Gene; 2014 Feb; 536(2):332-5. PubMed ID: 24361808
[TBL] [Abstract][Full Text] [Related]
6. [Diagnosis and treatment of syndrome of multiple endocrine neoplasia type 2].
Kuznetsov NS; Bel'tsevich DG; Poliakova EIu; Vasil'ev EV; Nemtsova MV
Khirurgiia (Mosk); 2002; (2):4-9. PubMed ID: 12418313
[TBL] [Abstract][Full Text] [Related]
7. [Pathogenic patterns of genetic predisposition to endocrine tumors].
Calender A
Nephrol Ther; 2006 Jan; 2 Suppl 2():S127-36. PubMed ID: 17373213
[TBL] [Abstract][Full Text] [Related]
8. Age-related neoplastic risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germ line RET Cys634Trp (TGC>TGG) mutation.
Milos IN; Frank-Raue K; Wohllk N; Maia AL; Pusiol E; Patocs A; Robledo M; Biarnes J; Barontini M; Links TP; de Groot JW; Dvorakova S; Peczkowska M; Rybicki LA; Sullivan M; Raue F; Zosin I; Eng C; Neumann HP
Endocr Relat Cancer; 2008 Dec; 15(4):1035-41. PubMed ID: 18794325
[TBL] [Abstract][Full Text] [Related]
9. RET proto-oncogene testing in infants presenting with Hirschsprung disease identifies 2 new multiple endocrine neoplasia 2A kindreds.
Fialkowski EA; DeBenedetti MK; Moley JF; Bachrach B
J Pediatr Surg; 2008 Jan; 43(1):188-90. PubMed ID: 18206480
[TBL] [Abstract][Full Text] [Related]
10. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW
Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
[TBL] [Abstract][Full Text] [Related]
11. Pediatric paraganglioma: an early manifestation of an adult disease secondary to germline mutations.
Mora J; Cascón A; Robledo M; Catala A
Pediatr Blood Cancer; 2006 Nov; 47(6):785-9. PubMed ID: 16304664
[TBL] [Abstract][Full Text] [Related]
12. Next-generation panel sequencing identifies
Gieldon L; Masjkur JR; Richter S; Därr R; Lahera M; Aust D; Zeugner S; Rump A; Hackmann K; Tzschach A; Januszewicz A; Prejbisz A; Eisenhofer G; Schrock E; Robledo M; Klink B
Eur J Endocrinol; 2018 Feb; 178(2):K1-K9. PubMed ID: 29158289
[TBL] [Abstract][Full Text] [Related]
13. Surgical management of hereditary pheochromocytoma.
Yip L; Lee JE; Shapiro SE; Waguespack SG; Sherman SI; Hoff AO; Gagel RF; Arens JF; Evans DB
J Am Coll Surg; 2004 Apr; 198(4):525-34; discussion 534-5. PubMed ID: 15051000
[TBL] [Abstract][Full Text] [Related]
14. RET mutation status in medullary thyroid cancer(MTC) patients and the significance of genetic screening for mutations in their immediate relatives--a preliminary report.
Menon MM; Simha MR
Indian J Pathol Microbiol; 2005 Apr; 48(2):161-5. PubMed ID: 16758654
[TBL] [Abstract][Full Text] [Related]
15. Tumours of familial origin in the head and neck.
Suárez C; Rodrigo JP; Ferlito A; Cabanillas R; Shaha AR; Rinaldo A
Oral Oncol; 2006 Nov; 42(10):965-78. PubMed ID: 16857415
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the role of RET polymorphisms/haplotypes as modifier loci for MEN 2, and analysis of the correlation with the type of RET mutation in a series of Spanish patients.
Fernández RM; Navarro E; Antiñolo G; Ruiz-Ferrer M; Borrego S
Int J Mol Med; 2006 Apr; 17(4):575-81. PubMed ID: 16525712
[TBL] [Abstract][Full Text] [Related]
17. Molecular diagnosis of multiple endocrine neoplasia Type 2.
Bugalho MJ; Domingues R; Sobrinho L
Expert Rev Mol Diagn; 2003 Nov; 3(6):769-79. PubMed ID: 14628904
[TBL] [Abstract][Full Text] [Related]
18. Genetic testing in pheochromocytoma: increasing importance for clinical decision making.
Bornstein SR; Gimenez-Roqueplo AP
Ann N Y Acad Sci; 2006 Aug; 1073():94-103. PubMed ID: 17102076
[TBL] [Abstract][Full Text] [Related]
19. Double germline mutations in the RET Proto-oncogene in MEN 2A and MEN 2B kindreds.
Dvorakova S; Vaclavikova E; Ryska A; Cap J; Vlcek P; Duskova J; Kodetova D; Holub V; Novak Z; Bendlova B
Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):192-6. PubMed ID: 16705552
[TBL] [Abstract][Full Text] [Related]
20. Rare syndromes.
Jabbour SA; Davidovici BB; Wolf R
Clin Dermatol; 2006; 24(4):299-316. PubMed ID: 16828412
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
